Insider Transactions in Q1 2021 at Neoleukin Therapeutics, Inc. (NLTX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
1,800
-0.13%
|
$19,800
$11.96 P/Share
|
|
Mar 24
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
1,800
-0.13%
|
$19,800
$11.95 P/Share
|
|
Mar 22
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
600
-0.04%
|
$7,200
$12.0 P/Share
|
|
Mar 17
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
1,200
-0.09%
|
$13,200
$11.36 P/Share
|
|
Mar 17
2021
|
Robert Ho Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,497
-23.2%
|
$71,467
$11.01 P/Share
|
|
Mar 16
2021
|
Robert Ho Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+47.17%
|
-
|
|
Mar 10
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
1,800
-0.13%
|
$19,800
$11.97 P/Share
|
|
Mar 03
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
1,800
-0.13%
|
$19,800
$11.87 P/Share
|
|
Feb 25
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
600
-0.04%
|
$7,800
$13.0 P/Share
|
|
Feb 24
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
1,800
-0.13%
|
$21,600
$12.14 P/Share
|
|
Feb 17
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
2,400
-0.17%
|
$28,800
$12.7 P/Share
|
|
Feb 10
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
3,000
-0.22%
|
$42,000
$14.2 P/Share
|
|
Feb 05
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
600
-0.04%
|
$8,400
$14.0 P/Share
|
|
Feb 03
2021
|
Carl Walkey Senior Vice President |
SELL
Open market or private sale
|
Direct |
2,400
-0.17%
|
$31,200
$13.23 P/Share
|